pharma news today obesity drugs glp-1 US-based giant Eli Lilly's diabetes and drug Mounjaro has emerged as the world's top-selling medicine, overtaking Merck's blockbuster cancer therapy Keytruda in a major shift for the global pharmaceutical industry GLP-1 drugs are famously super

During the titration phase, keep monitoring your blood sugar levels, weight changes, and side effects

Document storage and handling requirements in a laboratory record

Finally, confirm progressive overload

J Adv Nurs

Slower titration is worth considering if: Nausea persists beyond 2 weeks at your current dose You experience significant GI symptoms that interfere with daily function Your body aches or muscle pain are severe You are losing weight faster than 1 to 2 percent of body weight per week (too-rapid weight loss increases muscle loss risk) Some researchers use a 6 or 8-week interval between dose increases instead of the standard 4 weeks

Bijarnia, S., Wiley, V., Carpenter, K., Christodoulou, J., Ellaway, C